KEGG   DRUG: Ompekimig
Entry
D12985                      Drug                                   
Name
Ompekimig (USAN)
Formula
C8595H13243N2285O2705S56
Exact mass
193540.3310
Mol weight
193659.54
Sequence
(A chain)
DIQMTQSPSS LSASVGDRVT ITCKASESVD HFGWSLVHWY QQKPGKAPKL LIYRASNLES
GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQSNEDPW TFGGGTKVEI KRTVAAPSVF
IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGECGG GGSEVTLRES GPALVKPTQT
LTLTCTFSGF SLSNFGEGLS WIRQPPGKGL EWLAHIYWDD DKRYNPSLKS RLTISKDTSR
NQVVLTMTNM DPVDTATYYC ARRETVFYWY FDVWGQGTTV TVSSASTKGP SVFPLAPSSK
STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL
GTQTYICNVN HKPSNTKVDK KVEPKSCEKT HTCPPCPAPE AAGAPSVFLF PPKPKDTLMI
SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW
LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SREEMTKNQV SLTCEVKGFY
PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVLHEALH
SHYTQKSLSL SPGK
(B chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYWMYWVRQA PGKGLEWVAA ITPNAGEDYY
PESVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARGQ YYYTKYSLGY WGQGTLVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCRKTHTC PPCPAPEAAG
APSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSRLTVDKSR
WQQGNVFSCS VLHEALHSHY TQKSLSLSPG K
(C chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVAS ISSGDTTYYP
DSVKGRFTIS RDNAKNSLYL QMNSLRAEDT AVYYCARNEG YYFGLTLWGQ GTLVTVSSAS
TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS C
(D chain)
DIQMTQSPSS LSASVGDRVT ITCRASQSVD EEGDSYMNWY QQKPGKAPKL LIYAASNLES
GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQSNKDPP TFGGGTKVEI KRTVAAPSVF
IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
(E chain)
DIQMTQSPSS LSASVGDRVT ITCRASQPIH NHLDWYQQKP GKAPKLLIYF GKNLQEGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCFQ YKKGWSFGGG TKVEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: A23-A92, A138-A198, A218-C221, A245-A320, A371-A427, A447-D218, A453-B230, A456-B233, A488-A548, A594-A652, B22-B96, B148-B204, B224-E213, B265-B325, B371-B429, C22-C95, C145-C201, D23-D92, D138-D198, E23-E88, E133-E193)
  Type
Peptide
Class
Immunological agent
 DG02019  Interleukin inhibitor
Efficacy
Anti-inflammatory
  Type
Monoclonal antibody, multispecific antibody
Comment
Treatment of atopic dermatitis and other inflammatory medicated conditions
Target
IL13 [HSA:3596] [KO:K05435]
IL4 [HSA:3565] [KO:K05430]
IL33 [HSA:90865] [KO:K12967]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04657  IL-17 signaling pathway
hsa04658  Th1 and Th2 cell differentiation
Brite
Drug groups [BR:br08330]
 Immunological agent
  DG02019  Interleukin inhibitor
   D12985  Ompekimig
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interleukins
    IL4
     D12985  Ompekimig (USAN)
    IL13
     D12985  Ompekimig (USAN)
    IL33
     D12985  Ompekimig (USAN)
Other DBs
CAS: 2981477-39-6
PubChem: 504099501
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system